Britain's drug regulator Medicines and Healthcare Products Regulatory Agency (MHRA) said on Thursday that it would withdraw some medicines made by Wockhardt Ltd after it identified deficiencies in manufacturing procedures at Wockhardt's Waluj site in India.
Britain's drug regulator Medicines and Healthcare Products Regulatory Agency (MHRA) said on Thursday that it would withdraw some medicines made by Wockhardt Ltd after it identified deficiencies in manufacturing procedures at Wockhardt's Waluj site in India.
The 16 medicines affected by the precautionary recall include those used for the treatment of infections, high blood pressure, diabetes, epilepsy, depression, schizophrenia, Parkinson's disease, dementia in Alzheimer's patients and thyroid conditions.
The MHRA said patients did not need to return their medicines because there was no evidence that the medicines affected by the precautionary recall in the UK were defective.
"However, the MHRA has to act in the interests of public health as poor manufacturing standards cannot be allowed to continue," it said.
Copyright @ Thomson Reuters 2013
Sign Up with Google
RECOMMENDED FOR YOU
POPULAR